Sharp Therapeutics Corp.
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a proprietary IP-protected analytics platform that captu… Read more
Market Cap & Net Worth: Sharp Therapeutics Corp. (SHRX)
Sharp Therapeutics Corp. (V:SHRX) has a market capitalization of $47.12 Million (CA$67.67 Million) as of March 19, 2026. Listed on the V stock exchange, this Canada-based company holds position #24481 globally and #120 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sharp Therapeutics Corp.'s stock price CA$2.25 by its total outstanding shares 30075700 (30.08 Million).
Sharp Therapeutics Corp. Market Cap History: 2025 to 2026
Sharp Therapeutics Corp.'s market capitalization history from 2025 to 2026. Data shows growth from $52.35 Million to $47.12 Million (0.00% CAGR).
Sharp Therapeutics Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sharp Therapeutics Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SHRX by Market Capitalization
Companies near Sharp Therapeutics Corp. in the global market cap rankings as of March 19, 2026.
Key companies related to Sharp Therapeutics Corp. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Sharp Therapeutics Corp. Historical Marketcap From 2025 to 2026
Between 2025 and today, Sharp Therapeutics Corp.'s market cap moved from $52.35 Million to $ 47.12 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$47.12 Million | -10.00% |
| 2025 | CA$52.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sharp Therapeutics Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $47.12 Million USD |
| MoneyControl | $47.12 Million USD |
| MarketWatch | $47.12 Million USD |
| marketcap.company | $47.12 Million USD |
| Reuters | $47.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.